X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with PLETHICO PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PLETHICO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PLETHICO PHARMA UNICHEM LAB/
PLETHICO PHARMA
 
P/E (TTM) x 32.6 -1.1 - View Chart
P/BV x 3.4 0.0 20,508.7% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 UNICHEM LAB   PLETHICO PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
PLETHICO PHARMA
Mar-14
UNICHEM LAB/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs334395 84.6%   
Low Rs17431 555.9%   
Sales per share (Unadj.) Rs146.9604.4 24.3%  
Earnings per share (Unadj.) Rs11.932.5 36.6%  
Cash flow per share (Unadj.) Rs16.251.3 31.5%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.1473.6 22.2%  
Shares outstanding (eoy) m90.8434.08 266.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.70.4 490.4%   
Avg P/E ratio x21.46.6 325.5%  
P/CF ratio (eoy) x15.74.2 377.9%  
Price / Book Value ratio x2.40.5 537.0%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,0737,262 317.7%   
No. of employees `0005.7NA-   
Total wages/salary Rs m2,5581,596 160.3%   
Avg. sales/employee Rs Th2,352.5NM-  
Avg. wages/employee Rs Th450.9NM-  
Avg. net profit/employee Rs Th190.4NM-  
INCOME DATA
Net Sales Rs m13,34620,598 64.8%  
Other income Rs m192386 49.7%   
Total revenues Rs m13,53820,984 64.5%   
Gross profit Rs m1,6392,818 58.2%  
Depreciation Rs m390642 60.7%   
Interest Rs m291,593 1.8%   
Profit before tax Rs m1,412969 145.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293-138 -211.5%   
Profit after tax Rs m1,0801,107 97.6%  
Gross profit margin %12.313.7 89.8%  
Effective tax rate %20.7-14.3 -145.1%   
Net profit margin %8.15.4 150.7%  
BALANCE SHEET DATA
Current assets Rs m5,97918,877 31.7%   
Current liabilities Rs m2,43211,896 20.4%   
Net working cap to sales %26.633.9 78.4%  
Current ratio x2.51.6 154.9%  
Inventory Days Days6336 175.5%  
Debtors Days Days60198 30.5%  
Net fixed assets Rs m6,4039,861 64.9%   
Share capital Rs m182341 53.3%   
"Free" reserves Rs m9,29312,331 75.4%   
Net worth Rs m9,54816,139 59.2%   
Long term debt Rs m2304,706 4.9%   
Total assets Rs m12,84333,146 38.7%  
Interest coverage x50.01.6 3,111.6%   
Debt to equity ratio x00.3 8.3%  
Sales to assets ratio x1.00.6 167.2%   
Return on assets %8.68.1 106.0%  
Return on equity %11.36.9 165.0%  
Return on capital %14.312.3 116.7%  
Exports to sales %29.221.4 136.7%   
Imports to sales %6.315.2 41.7%   
Exports (fob) Rs m3,9004,402 88.6%   
Imports (cif) Rs m8473,136 27.0%   
Fx inflow Rs m4,3564,402 99.0%   
Fx outflow Rs m1,1623,184 36.5%   
Net fx Rs m3,1941,219 262.1%   
CASH FLOW
From Operations Rs m1,1192,437 45.9%  
From Investments Rs m-853-6,265 13.6%  
From Financial Activity Rs m-3342,490 -13.4%  
Net Cashflow Rs m-68-1,337 5.1%  

Share Holding

Indian Promoters % 50.1 82.7 60.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 4.3 351.2%  
FIIs % 3.0 5.5 54.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 7.5 422.7%  
Shareholders   20,176 10,665 189.2%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   J.B.CHEMICALS  VENUS REMEDIES  STERLING BIOTECH  CADILA HEALTHCARE  AUROBINDO PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens in Green; IT & Healthcare Stocks Gain(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.16% while the Hang Seng is down 0.49%. The Nikkei 225 is trading down by 0.43%.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 17, 2018 11:35 AM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - ALEMBIC PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS